12 results
The aim of this research is to gain a more detailed insight into the illness perceptions of patients with lung cancer. With this insight it is our aim to improve biopsychosocial care for these patients. Research question: What are the illness…
The aim is to examine whether care and treatment guided by structural psychosocial screening leads to a better quality of life and greater patient satisfaction than usual care alone in patients with lung cancer.
• To study the effect of treatment modalities immunotherapy (anti-PD1 or anti-PDL-1), and targeted therapy (crizotinib, gefitinib or erlotinib) on the size and diversity of lung carcinoma-specific T cell populations as measured by immune assays,…
To evaluate cost-effectiveness of a stepped care strategy to improve symptoms of depression or anxiety in patients treated for head and neck cancer or lung cancer.
The main objective of the study is to monitor the factors effecting success of PDT, namely oxygen, photosensitizer concentration and, light dose before and during illumination to gather data that can be clinically correlated and later implemented.
Primary Objective: To study the relationship between adherence and the plasma concentration of erlotinib and to study the relationship between side effects and adherence to erlotinib in patients with NSCLC.Secondary Objective: The study is partly of…
The primary goal of this study is to gain insight changes in components of nutritional status and functional capacity over time.The objective is to improve the multidisciplinary health care for lung cancer patients.Secundary goals are to investigate…
The primary objective is 1) to describe the long-term course of QoL in HNC patients and their informal caregivers and to identify cancer-related, personal, genetic, biological, psychobehavioural, physical, lifestyle-related, and social determinants…
To set up a biobank of prospectively collected tumor samples for genetic and immunological analysis, prior to and during IMA treatment.
The current study aims to recruit a greater number of lung cancer patients to measure tissue protein synthesis rates of non-small cell lung carcinomas and healthy lung tissue. The protein synthesis rates of healthy lung tissue will be compared to…
To determine whether the multimodal prehabilitation program (without extending the time from MDT meeting to operation beyond the DLCA-S norm of 3 weeks) for patients with NSCLC undergoing anatomical lung resection in MMC and ASz:1. is feasible 2.…
To examine the goals of patients and doctors for treatment with chemotherapy, immunotherapy or targeted therapy in metastatic lung cancer and whether these goals are achieved according to patients, doctors and relatives.